Overview
What is International Neuroendocrine Cancer Alliance?
The International Neuroendocrine Cancer Alliance is a globally focused nonprofit organization, acting as a powerful advocate for patients diagnosed with neuroendocrine cancer. Their primary objective is to serve as a unifying voice, fostering global collaboration and action towards supporting these patients. They aim to raise awareness about neuroendocrine cancers within the healthcare community and the general public, advocating for improved treatments and cures. The Alliance also disseminates accurate information about the disease, encourages research, and shares best practices with other neuroendocrine cancer organizations worldwide. Additionally, they offer educational meetings and events, such as Cancer Day, to increase awareness and support for patients and their families.
Is International Neuroendocrine Cancer Alliance legitimate?
International Neuroendocrine Cancer Alliance is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Neuroendocrine Cancer Alliance submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
What is the mission statement of International Neuroendocrine Cancer Alliance?
The International Neuroendocrine Cancer Alliance serves as a global advocate for neuroendocrine cancer patients. Its mission includes acting as a facilitator for global action, raising awareness about neuroendocrine cancer among healthcare professionals and the general public, supporting research to improve treatments and find cures, disseminating accurate information about the condition, fostering global collaboration among member organizations, and sharing best practices and experiences with other neuroendocrine cancer groups worldwide. The alliance also aims to mentor and guide the establishment of new patient and advocate groups, thereby strengthening the collective capacity to support individuals affected by neuroendocrine cancer.
Who is the CEO of International Neuroendocrine Cancer Alliance?
Mark Mcdonnell is the President of International Neuroendocrine Cancer Alliance.
What is the revenue of International Neuroendocrine Cancer Alliance?
International Neuroendocrine Cancer Alliance's revenue in 2022 was $257,057.
Who are the executives of International Neuroendocrine Cancer Alliance and what are their salaries?
There 10 volunteers at International Neuroendocrine Cancer Alliance.
Here are 6 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Where can I find the form 990 for International Neuroendocrine Cancer Alliance?
International Neuroendocrine Cancer Alliance's most recent form 990 was submitted in 2022 and can be accessed here.
Mission Statement of International Neuroendocrine Cancer Alliance
The International Neuroendocrine Cancer Alliance serves as a powerful advocate on a global scale, championing the needs and interests of neuroendocrine cancer patients. Its primary mission is multifaceted, encompassing various objectives. Firstly, the alliance aims to act as a global voice, providing support and facilitating collective action in the neuroendocrine cancer community. Secondly, it strives to elevate awareness about neuroendocrine cancer within the medical community and among the general public. Thirdly, the alliance is committed to fostering research efforts, with the ultimate goal of advancing treatments and potentially discovering cures for various forms of neuroendocrine cancer.
Furthermore, the International Neuroendocrine Cancer Alliance plays a crucial role in disseminating accurate information about neuroendocrine cancer. This mission is essential in empowering patients and their families, as well as the medical community, with reliable knowledge about the disease. In addition, the alliance seeks to bolster the efficacy of its member organizations and other neuroendocrine cancer groups worldwide by sharing best practices and experiences. This collaborative approach enables these groups to strengthen their capacities and improve the overall care and support provided to neuroendocrine cancer patients.
In summary, the International Neuroendocrine Cancer Alliance is dedicated to advocating for neuroendocrine cancer patients on a global scale. Its mission encompasses various aspects, including serving as a global voice, raising awareness, supporting research, disseminating information, and fostering collaboration among member organizations and other neuroendocrine cancer groups.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The International Neuroendocrine Cancer Alliance (INCA) significantly impacts the fight against neuroendocrine cancers through its role as a global advocate for patients. By raising awareness both within the healthcare community and the general public, INCA facilitates a deeper understanding of these complex diseases. The organization’s advocacy efforts help elevate the needs and experiences of neuroendocrine cancer patients, ensuring their voices are heard on a global scale.
INCA also plays a crucial role in supporting research initiatives aimed at developing better treatments and potential cures. By disseminating accurate information about neuroendocrine cancers, the organization empowers patients and healthcare providers with knowledge that can lead to more effective care and management strategies.
Additionally, INCA fosters collaboration among member organizations and other groups worldwide, sharing best practices and experiences to enhance capacity-building efforts. This collective approach promotes mentorship, guiding newly established patient groups while encouraging established organizations to strengthen their impact.
Through educational programs and awareness initiatives, such as Cancer Day events, INCA consistently works to enhance visibility and understanding of neuroendocrine cancers, making a lasting difference in the lives of patients and their families.
This information is meant to be a general summary of International Neuroendocrine Cancer Alliance. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $69
- Gross Receipts: $257,057
Assets and Liabilities:
- Total Assets: $320,758
- Total Liabilities: $0
- Net Assets: $320,758
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2013
Phone
(617) 630-6900Principal Officer
Mark Mcdonnell
Main Address
1150 Walnut Street, Newton, MA, 02461
NTEE Category
Code: G30 - Disease
If you are a representative of International Neuroendocrine Cancer Alliance and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.